Core Laboratories
CLB
194 hedge funds and large institutions have $1.05B invested in Core Laboratories in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 73 increasing their positions, 59 reducing their positions, and 29 closing their positions.
920% more call options, than puts
Call options by funds: $3.06M | Put options by funds: $300K
26% more capital invested
Capital invested by funds: $830M → $1.05B (+$218M)
24% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 59
6.42% more ownership
Funds ownership: 103.75% → 110.17% (+6.4%)
3% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 29
2% less funds holding
Funds holding: 197 → 194 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
+$64.5M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$16.4M |
| 3 |
EARNEST Partners
Atlanta,
Georgia
|
+$3.46M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$2.78M |
| 5 |
Legal & General Group
London,
United Kingdom
|
+$2.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$9.44M |
| 2 |
FAM
Fred Alger Management
New York
|
-$5.63M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$5.55M |
| 4 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$3.37M |
| 5 |
BlackRock
New York
|
-$3.21M |
CLB Hedge Fund Activity: Q2 2024 in Review
194 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q2 2024, worth a combined $1.05B — up 26% from $830M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of CLB and 28 opened new positions — a net loss of 1 holder — while 59 trimmed existing stakes and 73 added.
The largest buyer was Disciplined Growth Investors, adding an estimated $64.5M. The largest seller was Ariel Investments, cutting an estimated $9.44M.
- 194 institutional investors held Core Laboratories (CLB) as of Q2 2024, down from 197 in Q1 2024.
- Funds reported $1.05B of Core Laboratories stock for Q2 2024, up 26% quarter-over-quarter.
- 28 funds opened new Core Laboratories positions in Q2 2024 and 29 closed out, a net change of -1 holder.
- The largest Core Laboratories buyer in Q2 2024 was Disciplined Growth Investors, an estimated $64.5M added.
- The largest Core Laboratories seller in Q2 2024 was Ariel Investments, an estimated $9.44M sold.
Based on aggregated 13F filings for Q2 2024.